Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.44 (
P-glycoprotein
)
13,344
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
P-glycoprotein
(
P-gp
) mediates a multidrug resistance (MDR) phenotype in tumor cell lines selected with lipophilic cytotoxic drugs. Transport studies using purified
P-glycoprotein
reconstituted into defined liposomes have shown energy-dependent drug efflux of structurally dissimilar drugs. In this report, we have examined the effects of N-ethylmaleimide, a potent inhibitor of the
P-gp
ATPase, on
P-gp
drug binding in intact MDR cells and in plasma membranes. Our results show that short term treatment of MDR cells with 1-50 microM N-ethylmaleimide led to a concentration dependent increase in
P-gp
photoaffinity labeling with iodoaryl-azidoparazosin (IAAP). In addition, N-ethylmaleimide increases [3H] vinblastine accumu-lation in drug-resistant but not in sensitive cells. Comparison of IAAP photolabeled
P-gp
from intact cells with or without N-ethylmaleimide treatment did not show differences in the pattern of IAAP photolabeled peptides. Thus, the observed increase in
P-gp
photolabeling with IAAP in N-ethylmaleimide treated cells is not due to photolabeling at different sites. Incubation of MDR cells with [14C] N-ethylmaleimide showed that
P-gp
is directly modified at several Cysteine residues, as found from a complete proteolytic digestion of [14C] Nethylmaleimide labeled
P-gp
. The comparison of V8
staphylococcus
aureas peptides from [14C] Nethylmaleimide or IAAP modified
P-gp
showed some peptides to co-migrate on SDS PAGE. However, modification of plasma membranes from drug resistant cells treated with N-ethylmaleimide did not show a dose-dependent increase in
P-gp
photolabeling with IAAP as seen with intact MDR cells. Interestingly, N-ethylmaleimide increases
P-gp
phosphorylation by inhibiting the turnover of Pgp phosphates. However, inhibition of
P-gp
phosphorylation with calyculin A did not show an increase in
P-gp
photolabeling in MDR cells. Taken together, the results of this study suggest that N-ethylmaleimide potentiates
P-gp
photolabeling with IAAP by inhibiting
P-gp
ATPase thereby increasing the local concentration of IAAP in intact MDR cells. Furthermore, inhibition of
P-gp
ATPase by N-ethylmaleimide does not lead to conformational changes that affects
P-gp
drug binding.
...
PMID:N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells. 906 77